Table 3.
Acute impact of ablation
| Total cases with terminations during ablation | Cases terminating to SR | Cases terminating to AT | |
|---|---|---|---|
| De Novo PAF (n=41) | 27(65%) | 18 | 9 |
| Redo PAF (n=38) | 24(64%) | 15 | 9 |
| Persistent AF (n=96) | 32(33%) | 16 | 16 |
Acute impact of ablation
| Total cases with terminations during ablation | Cases terminating to SR | Cases terminating to AT | |
|---|---|---|---|
| De Novo PAF (n=41) | 27(65%) | 18 | 9 |
| Redo PAF (n=38) | 24(64%) | 15 | 9 |
| Persistent AF (n=96) | 32(33%) | 16 | 16 |